HOME > TOP STORIES
TOP STORIES
-
TRENDS Top 10 PHARMA JAPAN Stories in 2018
December 26, 2018
-
BUSINESS Some Drug Makers Stop Distributing 2019 Calendars with Revised JPMA Code of Practice Set to Take Effect in January
December 25, 2018
-
REGULATORY MHLW OKs Add’l Indications for Keytruda, Tecentriq, Hemlibra, and More
December 25, 2018
-
REGULATORY After Settling on October 2019 Re-Pricing, When Will Govt Reveal New Drug Prices?
December 21, 2018
-
REGULATORY PhRMA, EFPIA Pitch Enhanced Appraisal Model for Japan HTA Plan; Chuikyo Reps Acknowledge ICER Limitations
December 20, 2018
-
REGULATORY Govt to Pare Drug Prices by 2.4% in October 2019 Ad-Hoc Re-Pricing
December 19, 2018
-
BUSINESS Takeda Likely to Make NYSE Debut on Christmas Eve
December 19, 2018
-
REGULATORY Ministers Agree on Ad-Hoc Drug Re-Pricing in October 2019, 29 Billion Yen Saving in State Coffers
December 18, 2018
-
COMMENTARY LDP Draws Up Tax Reform Outline, Revamps Credits for R&D Expenses
December 17, 2018
-
BUSINESS Astellas Makes Full Inroads into I/O Arena with Potenza Buyout
December 17, 2018
-
BUSINESS Lundbeck Japan to Quadruple Workforce by Next Summer, Eyes Vortioxetine Launch: Chief
December 14, 2018
-
BUSINESS Astellas CEO Sees Cell Therapy Biz Model Established by “around 2030”
December 14, 2018
-
REGULATORY Govt to Tap R&D Tax Credit System to Push Research on Pediatric Use, Superbug Fight
December 13, 2018
-
REGULATORY Chuikyo Adopts Outline of 2019 Drug Price Revision for Sales Tax Hike
December 13, 2018
-
BUSINESS Armed with 2 New Drugs, EA Pharma Looks to Raise Profile in Chronic Constipation Space
December 12, 2018
-
REGULATORY MHLW to Offer Free Rubella Shots to Men Aged 39-56
December 12, 2018
-
REGULATORY Govt’s Draft Reform Timeline Prods MHLW to Discuss Use of “Economic Evaluations” in Reimbursement Decisions in FY2019
December 11, 2018
-
REGULATORY Big Improvement in Single-Product, Single-Price Transaction Rate in April-Sept.; Over 90% with Dispensing Pharmacy Chains
December 11, 2018
-
REGULATORY R&D Tax Credit Refit Taking Shape; Open Innovation Scheme Likely to Cover Research Commissioned to Big Firms
December 10, 2018
-
REGULATORY JPMA Official Renews Call for Use of “Specified Clinical Research” Data in Application Dossiers
December 7, 2018
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
